welcome to the belle capital usa website

Masthead Image

Pam ContagPam Contag PhD

Technology Council

CEO Cygnet Biofuels, San Jose, CA

Pamela R. Contag, Ph.D., is currently the CEO of Cygnet Biofuels and the CSO of Origen Therapeutics. Dr. Contag founded four venture-backed start-up companies; Xenogen Corp. completed a public offering in 2004 and was subsequently acquired; Cobalt Technologies, now in product demonstration; Cygnet Biofuels, developing low cost enzymes; and ConcentRx, a novel therapeutic for oncology indications. Dr. Contag was named one of the "Top 25 Women in Small Business" by Fortune magazine. Dr. Contag has held various consulting and board positions, public, private and not-for-profit. Those positions include a consulting Professorship at Stanford School of Medicine in the Department of Pediatrics (1999-present), the Dean's Advisory Board of the Johns Hopkins Bloomberg School of Public Health (1999-2005). Dr. Contag was a Director of Xenogen Corporation (Nasdaq) (1995-2005) and was CEO and Chairman of Cobalt Technologies (2005-2008) and a Delcath (Nasdaq) Board Member (2008-2011). She also joined in 2009 the DOE Biomass technology Advisory Committee and two nonprofit boards, Springboard Enterprises, an accelerator of women entrepreneurs and the Molecular Sciences Institute. In 2010 Dr. Contag joined the Merrick Engineering Consultancy specializing in the energy field. With more than 25 years of microbiology research experience, Dr. Contag is widely published in the field of Microbiology and Optical imaging and has over 36 patents and patent applications. Dr. Contag received her Ph.D. in Microbiology at the University of Minnesota Medical School in 1989 and completed her Postdoctoral Training at Stanford University School of Medicine in 1993 specializing in "Host/Pathogen Interactions".


NopSec and Qualys Partner to Offer Enhanced Security and Compliance Analytics

New Security Findings--Apple Isn't Immune And Fixing Takes Too Long

List of Female Angel and Early-Stage Investors in Tech

Cardialen Raises Additional $1.5 million

UNopsec Selected for 20 Most Promising Security Companies for 2015

US Bancorp Invests in Finomial Platform

The Top Angels in Tech

20 Lesser Known Angels Crushing it

7 Things Investors Love To See

Do Women Entrepreneurs Invest Differently From Men?

How Belle Capital USA invests in women-run tech startups

Current Motor Rolls Out 'Mini-Fleet' Solar Station And Electric Scooters

President Obama praises Current Motor board member & strategic assembly partner, Andra Rush

Current Motor in MotorWeek

Finomial Finomial Helps Hedge Funds Deploy in the Cloud

Finomial's Automated Solution to Help Relieve FATCA burden

NopSec recognized as 2013 "Emerging Security Vendor" by CRN Magazine

Lessons From a Startup That Got Away

The New Girls Network: Building A Bigger Pie For High-Growth Women-Led Companies

Human Capital, the Doorway to Financial Capital

Betting on Women in STEM

7 Things Investors Love To See

BELLE Managing Director Lauren Flanagan and Advisor Ingrid Vanderveldt Named to 40 Women Over 40 to Watch

Dell's Secret Weapon, Entrepreneur-in-Residence and BELLE advisor, Ingrid Vanderveldt

Current Motor at NAIAS, Detroit Auto Show

Car Talk
Detroit 2013: It's Not Always Easy Being Green

NAIAS 2013: Current Motor Company Scooters

Midwest Energy News
At Detroit auto show, electric vehicles still make a splash

Current Motor's Partnership with Dakkota Integrated Systems Powers Growth Engine

SPINS Acquires Third Solutions

Epson Partners with Third Solutions

Detroit Free Press
Tart Cherry Industry Touts Health Benefits

Lauren Flanagan named to BusinessWeek's Top 25 Angels in Tech